Bio-Rad Laboratories, Inc.
US ˙ NYSE ˙ US0905722072

SecurityBIO / Bio-Rad Laboratories, Inc.
InstitutionCaptrust Financial Advisors
Latest Disclosed Ownership1,003 shares
Latest Disclosed Value $ 279,586
Captrust Financial Advisors reports 12.44% increase in ownership of BIO / Bio-Rad Laboratories, Inc.

On May 14, 2026 - Captrust Financial Advisors filed a 13F-HR form disclosing ownership of 1,003 shares of Bio-Rad Laboratories, Inc. (US:BIO) valued at $279,586 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 892 shares of Bio-Rad Laboratories, Inc.. This represents a change in shares of 12.44% during the quarter. The current value of the position is $308,422 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F BIO RAD LABS INC CL A Stock 090572207 1,003 111 12.44 280 3.33 0.0005
2026-02-17 2025-12-31 13F BIO RAD LABS INC CL A Stock 090572207 892 20 2.29 270 10.66 0.0005
2025-11-19 2025-09-30 13F BIO RAD LABS INC CL A Stock 090572207 872 872 244 0.0005
2025-08-15 2025-06-30 13F BIO RAD LABS INC CL A Stock 090572207 0 -7,704 -100.00 0 -100.00
2025-05-15 2025-03-31 13F BIO RAD LABS INC CL A Stock 090572207 7,704 1,974 34.45 1,876 -0.32 0.0047
2025-02-14 2024-12-31 13F BIO RAD LABS INC CL A Stock 090572207 5,730 4,964 648.04 1,882 635.16 0.0054
2024-11-14 2024-09-30 13F BIO RAD LABS INC CL A Stock 090572207 766 -226 -22.78 256 -5.19 0.0008
2024-08-15 2024-06-30 13F BIO RAD LABS INC CL A Stock 090572207 992 -695 -41.20 271 -53.69 0.0009
2024-05-15 2024-03-31 13F BIO RAD LABS INC CL A Stock 090572207 1,687 -37 -2.15 584 4.86 0.0021
2024-02-14 2023-12-31 13F BIO RAD LABS INC CL A Stock 090572207 1,724 97 5.96 557 -4.63 0.0019
2023-11-15 2023-09-30 13F BIO RAD LABS INC CL A Stock 090572207 1,627 -238 -12.76 583 -17.54 0.0022
2023-08-15 2023-06-30 13F BIO RAD LABS INC CL A Stock 090572207 1,865 743 66.22 707 31.66 0.0028
2023-05-15 2023-03-31 13F BIO RAD LABS INC CL A Stock 090572207 1,122 155 16.03 538 32.27 0.0024
2023-02-15 2022-12-31 13F BIO RAD LABS INC CL A Stock 090572207 967 194 25.10 407 26.09 0.0020
2022-11-16 2022-09-30 13F BIO RAD LABS INC CL A Stock 090572207 773 -8 -1.02 322 -16.80 0.0019
2022-08-23 2022-06-30 13F/A-1 BIO RAD LABS INC CL A Common Stock 090572207 781 49 6.69 387 -6.07 0.0025
2022-08-16 2022-06-30 13F BIO RAD LABS INC CL A COM 090572207 1,111 379 550 0.0040
2022-05-16 2022-03-31 13F BIO RAD LABS CL A 090572207 732 135 22.61 412 -8.65 0.0027
2022-02-14 2021-12-31 13F BIO RAD LABS INC CL A Common Stock 090572207 597 -89 -12.97 451 -11.91 0.0031
2021-11-16 2021-09-30 13F BIO RAD LABS INC CL A Common Stock 090572207 686 40 6.19 512 23.08 0.0043
2021-08-16 2021-06-30 13F BIO RAD LABS INC CL A Common Stock 090572207 646 46 7.67 416 21.28 0.0039
2021-05-17 2021-03-31 13F BIO RAD LABS INC CL A Common Stock 090572207 600 522 669.23 343 662.22 0.0037
2021-02-16 2020-12-31 13F BIO RAD LABS INC CL A Common Stock 090572207 78 -2 -2.50 45 7.14 0.0006
2020-11-17 2020-09-30 13F BIO RAD LABS INC CL A Common Stock 090572207 80 50 166.67 42 200.00 0.0007
2020-08-14 2020-06-30 13F BIO RAD LABS INC CL A Common Stock 090572207 30 30 14 0.0002
2020-02-14 2019-12-31 13F BIO RAD LABS INC CL A Common Stock 090572207 0 -6 -100.00 0 -100.00
2019-11-14 2019-09-30 13F BIO RAD LABS INC CL A Common Stock 090572207 6 0 0.00 2 0.00 0.0001
2019-08-13 2019-06-30 13F BIO RAD LABS INC CL A Common Stock 090572207 6 0 0.00 2 0.00 0.0001
2019-05-15 2019-03-31 13F BIO RAD LABS INC CL A Common Stock 090572207 6 0 0.00 2 100.00 0.0001
2019-02-13 2018-12-31 13F BIO RAD LABS INC CL A Common Stock 090572207 6 -4 -40.00 1 -66.67 0.0001
2018-11-15 2018-09-30 13F BIO RAD LABS INC CL A Common Stock 090572207 10 -178 -94.68 3 -94.44 0.0001
2018-08-13 2018-06-30 13F BIO RAD LABS INC CL A Common Stock 090572207 188 10 5.62 54 22.73 0.0030
2018-05-15 2018-03-31 13F BIO RAD LABS INC CL A Common Stock 090572207 178 -108 -37.76 44 -35.29 0.0027
2018-02-14 2017-12-31 13F BIO RAD LABS INC CL A Common Stock 090572207 286 286 68 0.0041
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.